D-0702-2026 Class II Ongoing
FDA drug recall D-0702-2026 was initiated by Major Pharmaceuticals on Jul 13, 2026 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 29, 2026
- Initiation Date
- Jul 13, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6951-61
Reason for recall
Subpotent Drug
Distribution pattern
Nationwide in the USA.
Code information
Lot# N02172, exp 07/2026; N02296, N02288, Exp. Date 12/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0702-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026